The Institute of Medicine (IOM) got it all wrong when it came out with its recommendation to eliminate 510(k). For details on what the IOM and how AdvaMed responded, see the Perspectives blogs by Sherrie Conroy for Sept 16 and July 29.

This month's Reader poll asks: Is AdvaMed effectively representing industry concerns over the 510(k) product review process? Tell us what you think at www.MedicalDesign.com